At a high - level meeting at WHO,
vaccine manufacturers said they might be able to produce more vaccine earlier than they thought
Not exact matches
Manufacturer Says Some Lots of H1N1 Lost Potency None of the H1N1 vaccine involved in a voluntary manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials conf
Manufacturer Says Some Lots of H1N1 Lost Potency None of the H1N1
vaccine involved in a voluntary
manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials conf
manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials confirmed today.
Some
Vaccine in Latest Recall Administered by Oneida County Health Department «Potency of Nasal Spray Vaccine in Question — Safety Not an Issue» The Oneida County Health Department's current supply of H1N1 flu vaccine will not be affected by the latest voluntary manufacturer's recall of the product, Daniel W. Gilmore, Acting Director of the departmen
Vaccine in Latest Recall Administered by Oneida County Health Department «Potency of Nasal Spray
Vaccine in Question — Safety Not an Issue» The Oneida County Health Department's current supply of H1N1 flu vaccine will not be affected by the latest voluntary manufacturer's recall of the product, Daniel W. Gilmore, Acting Director of the departmen
Vaccine in Question — Safety Not an Issue» The Oneida County Health Department's current supply of H1N1 flu
vaccine will not be affected by the latest voluntary manufacturer's recall of the product, Daniel W. Gilmore, Acting Director of the departmen
vaccine will not be affected by the latest voluntary
manufacturer's recall of the product, Daniel W. Gilmore, Acting Director of the department
said.
No Recalled
Vaccine Shipped to Oneida County Health Manufacturer Says Some Lots of H1N1 Lost Potency None of the H1N1 vaccine involved in a voluntary manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials confirmed
Vaccine Shipped to Oneida County Health
Manufacturer Says Some Lots of H1N1 Lost Potency None of the H1N1 vaccine involved in a voluntary manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials conf
Manufacturer Says Some Lots of H1N1 Lost Potency None of the H1N1
vaccine involved in a voluntary manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials confirmed
vaccine involved in a voluntary
manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials conf
manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials confirmed today.
The shortage also has become an issue on the campaign trail, with Democratic candidate Sen. John Kerry blaming the Bush administration for not paying attention to warning signs about possible shortages and the Bush campaign inferring that
vaccine manufacturers are hindered by fears of lawsuits, something the campaign
said Kerry would not move to fix.
The
manufacturer of the sole dengue
vaccine on the market
says a new study shows that it should only be used in people who have had a previous infection from the mosquito - borne virus.
«The issue is not influenza
vaccines in general, but one
manufacturer's
vaccine in one year,» he
says.
One of the Lyon - based investors is
vaccine manufacturer Sanofi Pasteur, whose president, Jacques Berger, sees many benefits to the changes: «There's no rivalry between those who want to work in state - funded research and those who want to work in the private sector,» he
says.
At this point, the U.S. government expects
manufacturers to deliver 45 million to 52 million doses of the
vaccine by mid-October,
said Jay Butler, head of the H1N1 task force for the U.S. Centers for Disease Control and Prevention.
They
say that opening companies up to lawsuits «could drive
vaccine manufacturers from the market and halt the future production and development of childhood
vaccines in this country.»
Supporters of the AMC concept
say that it addresses an immediate problem by providing a reason for
manufacturers to provide pneumococcal
vaccines to needy populations.
Unlike other medical treatments for which companies are driven to keep their products safe because of liability threats, their brief
says «the
Vaccine Program itself provides no incentive to vaccine manufacturers to make their vaccines safer.
Vaccine Program itself provides no incentive to
vaccine manufacturers to make their vaccines safer.
vaccine manufacturers to make their
vaccines safer.»
Nearly 80 million people in 77 countries received the influenza
vaccine with WHO's help — including providing a «seed» strain of the virus used by
manufacturers — but the report
says that «numerous systemic difficulties» slowed distribution to low - resource countries.
Frieden, who called the delays «enormously frustrating,»
said manufacturers have difficulty growing the viruses used to make
vaccine.
Vaccine manufacturers have notified officials that they can't make good on their targets, Anne Schuchat, director of CDC's National Center for Immunization and Respiratory Diseases,
said during a press conference today.
«Such a system would address barriers to
vaccine manufacturers» participation as well as individual perceptions that fuel
vaccine hesitancy in low - resource counties,» Halabi
said.
In a dissenting opinion, they accused the court of imposing «its own bare policy preferences» to protect
vaccine manufacturers and
said it was important for companies to be pushed, at times by litigation, to improve on existing
vaccines.
«Because viruses typically mutate during
vaccine production,
manufacturers have to screen for mutations, and decide which ones can be tolerated and which ones can't,» Heaton
said.
Several companies and federal agencies have already contacted him about the influenza A and influenza B backbones, Kawaoka
says, and he is hopeful the systems can be adopted by
vaccine manufacturers and grown in cell culture facilities already available in the United States and Japan.
Sanjay Gurunathan from Sanofi Pasteur,
manufacturer of one of the
vaccines used in RV144,
said a new partnership of the US National Institute of Allergy and Infectious Diseases, The Bill & Melinda Gates Foundation, HIV
Vaccine Trials Network, US Military HIV Research Program (MHRP), and Sanofi Pasteur — known as the Pox Protein Public Private Partnership, or P5 — will aim to increase vaccine efficacy from the 31.2 percent of the RV144 trial to 50 p
Vaccine Trials Network, US Military HIV Research Program (MHRP), and Sanofi Pasteur — known as the Pox Protein Public Private Partnership, or P5 — will aim to increase
vaccine efficacy from the 31.2 percent of the RV144 trial to 50 p
vaccine efficacy from the 31.2 percent of the RV144 trial to 50 percent.
Merck, itself a multinational
vaccine manufacturer, states in The Merck Manual of Diagnosis and Therapy that autoimmune haemolytic anaemia may be caused by modified live - virus
vaccines, as do Tizard's Veterinary Immunology (4th edition) and the Journal of Veterinary Internal Medicine.6 The British Government's Working Group, despite being staffed by
vaccine - industry consultants who
say they are independent, also acknowledged this fact.
Dodds
says that after 20 years of following the United States Department of Agriculture and the drug
manufacturer's recommendations to make annual
vaccines a standard in veterinary care, professionals who first challenged the standard school of thought were considered rebels.
Cecil Metzger, a spokesman for Norden Laboratories in Lincoln, Neb., one of the nation's largest
manufacturers of rabies
vaccines,
said his company and others don't make blanket recommendations for annual inoculations.
«While the
vaccines may have a three - year duration, the
manufacturers still recommend annual shots,»
said Xan Rawls, Brevard County animal control director.
One American veterinary
vaccine manufacturer has made a public announcement,
saying that it no longer recommends annual vaccination.